Greenleaf Trust Has $761,000 Stock Position in CVS Health Co. (NYSE:CVS)

Greenleaf Trust lowered its stake in shares of CVS Health Co. (NYSE:CVS) by 27.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,949 shares of the pharmacy operator’s stock after selling 6,452 shares during the quarter. Greenleaf Trust’s holdings in CVS Health were worth $761,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Copeland Capital Management LLC bought a new position in CVS Health during the fourth quarter valued at $104,000. Avantra Family Wealth Inc. purchased a new position in shares of CVS Health in the fourth quarter worth about $506,000. Spire Wealth Management lifted its stake in shares of CVS Health by 27.0% during the 4th quarter. Spire Wealth Management now owns 12,397 shares of the pharmacy operator’s stock valued at $556,000 after buying an additional 2,634 shares in the last quarter. Deroy & Devereaux Private Investment Counsel Inc. bought a new stake in shares of CVS Health during the 4th quarter valued at $17,709,000. Finally, Tokio Marine Asset Management Co. Ltd. lifted its holdings in shares of CVS Health by 4.3% in the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 35,110 shares of the pharmacy operator’s stock worth $1,576,000 after buying an additional 1,450 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CVS has been the subject of several analyst reports. Royal Bank of Canada cut their price target on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday, November 15th. Evercore ISI raised their price objective on shares of CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a research report on Monday, January 27th. UBS Group upped their target price on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research report on Thursday, November 7th. TD Cowen lifted their price target on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. Finally, Mizuho cut their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $68.12.

CVS Health Price Performance

CVS opened at $56.39 on Wednesday. The stock’s 50 day moving average price is $51.16 and its 200-day moving average price is $56.09. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The stock has a market capitalization of $70.96 billion, a PE ratio of 14.31, a price-to-earnings-growth ratio of 0.62 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.21 EPS. On average, equities research analysts predict that CVS Health Co. will post 5.14 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.72%. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.